SLU-PP-332 Tablets

What is SLU-PP-332 Tablets

SLU-PP-332 Tablets are a tablet-formulated version of the REV-ERBα/β agonist compound used in research exploring metabolic function and circadian rhythm regulation. They allow for convenient oral administration in laboratory settings.

Benefits of SLU-PP-332 Tablets
- Easy-to-dose oral form of SLU-PP-332  
- May support metabolic and circadian studies  
- Investigated for fat loss and energy modulation  
- Potential role in inflammation control  

How to Use SLU-PP-332 Tablets
Previous research dosages used: 10mg to 30mg per day orally, typically in divided doses. Exact usage depends on study goals and subject model.